Literature DB >> 29227512

Efficacy and Safety Comparison Between Suberoylanilide Hydroxamic Acid and Mitomycin C in Reducing the Risk of Corneal Haze After PRK Treatment In Vivo.

Govindaraj Anumanthan, Ajay Sharma, Michael Waggoner, Chuck W Hamm, Suneel Gupta, Nathan P Hesemann, Rajiv R Mohan.   

Abstract

PURPOSE: This study compared the efficacy and safety of suberoylanilide hydroxamic acid (SAHA) and mitomycin C (MMC) up to 4 months in the prevention of corneal haze induced by photorefractive keratectomy (PRK) in rabbits in vivo.
METHODS: Corneal haze in rabbits was produced with -9.00 diopter PRK. A single application of SAHA (25 μM) or MMC (0.02%) was applied topically immediately after PRK. Effects of the two drugs were analyzed by slit-lamp microscope, specular microscope, TUNEL assay, and immunofluorescence.
RESULTS: Single topical adjunct use of SAHA (25 μM) or MMC (0.02%) after PRK attenuated more than 95% corneal haze and myofibroblast formation (P < .001). SAHA did not reduce keratocyte density, cause keratocyte apoptosis, or increase immune cell infiltration compared to MMC (P < .01 or .001). Furthermore, SAHA dosing did not compromise corneal endothelial phenotype, density, or function in rabbit eyes, whereas MMC application did (P < .01 or .001).
CONCLUSIONS: SAHA and MMC significantly decreased corneal haze after PRK in rabbits in vivo. SAHA exhibited significantly reduced short- and long-term damage to the corneal endothelium compared to MMC in rabbits. SAHA is an effective and potentially safer alternative to MMC for the prevention of corneal haze after PRK. Clinical trials are warranted. [J Refract Surg. 2017;33(12):834-839.]. Copyright 2017, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29227512      PMCID: PMC9248033          DOI: 10.3928/1081597X-20170921-02

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.255


  26 in total

Review 1.  Excimer laser surface ablation: a review of recent literature.

Authors:  David P S O'Brart
Journal:  Clin Exp Optom       Date:  2013-05-08       Impact factor: 2.742

Review 2.  Wounding the cornea to learn how it heals.

Authors:  Mary Ann Stepp; James D Zieske; Vickery Trinkaus-Randall; Briana M Kyne; Sonali Pal-Ghosh; Gauri Tadvalkar; Ahdeah Pajoohesh-Ganji
Journal:  Exp Eye Res       Date:  2014-03-04       Impact factor: 3.467

3.  Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK.

Authors:  Rahul R Mohan; Audrey E K Hutcheon; Rosan Choi; JongWook Hong; JongSoo Lee; Rajiv R Mohan; Renato Ambrósio; James D Zieske; Steven E Wilson
Journal:  Exp Eye Res       Date:  2003-01       Impact factor: 3.467

Review 4.  Corneal myofibroblast biology and pathobiology: generation, persistence, and transparency.

Authors:  Steven E Wilson
Journal:  Exp Eye Res       Date:  2012-04-20       Impact factor: 3.467

5.  Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial.

Authors:  Nader Nassiri; Saman Farahangiz; Mohammad Rahnavardi; Laleh Rahmani; Nariman Nassiri
Journal:  J Cataract Refract Surg       Date:  2008-06       Impact factor: 3.351

6.  Effect of mitomycin-C on the variance in refractive outcomes after photorefractive keratectomy.

Authors:  Mary Ellen Sy; Lijun Zhang; Allen Yeroushalmi; Derek Huang; D Rex Hamilton
Journal:  J Cataract Refract Surg       Date:  2014-10-08       Impact factor: 3.351

7.  Molecular mechanisms of suberoylanilide hydroxamic acid in the inhibition of TGF-β1-mediated canine corneal fibrosis.

Authors:  Kristina M Gronkiewicz; Elizabeth A Giuliano; Ajay Sharma; Rajiv R Mohan
Journal:  Vet Ophthalmol       Date:  2015-11-12       Impact factor: 1.644

8.  BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo.

Authors:  Ashish Tandon; Ajay Sharma; Jason T Rodier; Alexander M Klibanov; Frank G Rieger; Rajiv R Mohan
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

9.  Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy.

Authors:  Dennis H Goldsberry; Randy J Epstein; Parag A Majmudar; Rachel H Epstein; Richard F Dennis; Glenn Holley; Henry F Edelhauser
Journal:  J Refract Surg       Date:  2007-09       Impact factor: 3.573

10.  Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer.

Authors:  Ajay Sharma; Jason T Rodier; Ashish Tandon; Alexander M Klibanov; Rajiv R Mohan
Journal:  Mol Vis       Date:  2012-10-20       Impact factor: 2.367

View more
  5 in total

1.  [Corneal complications after PRK for hyperopia].

Authors:  Christoph Lwowski; Thomas Kohnen
Journal:  Ophthalmologe       Date:  2020-02       Impact factor: 1.059

2.  Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo.

Authors:  Suneel Gupta; Michael K Fink; Duraisamy Kempuraj; Nishant R Sinha; Lynn M Martin; Landon M Keele; Prashant R Sinha; Elizabeth A Giuliano; Nathan P Hesemann; Sudhanshu P Raikwar; Shyam S Chaurasia; Rajiv R Mohan
Journal:  Mol Ther       Date:  2022-07-02       Impact factor: 12.910

Review 3.  A Critical Overview of the Biological Effects of Mitomycin C Application on the Cornea Following Refractive Surgery.

Authors:  Esther Arranz-Marquez; Andreas Katsanos; Vassilios P Kozobolis; Anastasios G P Konstas; Miguel A Teus
Journal:  Adv Ther       Date:  2019-03-11       Impact factor: 3.845

4.  A Novel Topical Ophthalmic Formulation to Mitigate Acute Mustard Gas Keratopathy In Vivo: A Pilot Study.

Authors:  Ratnakar Tripathi; Praveen K Balne; Nishant R Sinha; Lynn M Martin; Sabeeh Kamil; James R Landreneau; Suneel Gupta; Jason T Rodier; Prashant R Sinha; Nathan P Hesemann; Alexandria C Hofmann; Michael K Fink; Shyam S Chaurasia; Rajiv R Mohan
Journal:  Transl Vis Sci Technol       Date:  2020-11-02       Impact factor: 3.283

5.  Safety and efficacy of combination of suberoylamilide hydroxyamic acid and mitomycin C in reducing pro-fibrotic changes in human corneal epithelial cells.

Authors:  Rohit Shetty; Nimisha Rajiv Kumar; Murali Subramani; Lekshmi Krishna; Ponnalagu Murugeswari; Himanshu Matalia; Pooja Khamar; Zelda V Dadachanji; Rajiv R Mohan; Arkasubhra Ghosh; Debashish Das
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.